Table 2 Patterns of cannabidiol use in 287 cannabidiol users
| Â | N (%) |
|---|---|
Length of CBD use (n = 387) | |
 0–3 months | 8 (2.1%) |
 3–6 months | 145 (37.7%) |
 6–12 months | 115 (29.9%) |
 1–2 years | 64 (16.6%) |
 2–5 years | 37 (9.6%) |
 More than 5 years | 16 (4.1%) |
Time of day used (n = 387) | |
 Morning | 70 (18.1%) |
 Evening | 99 (25.6%) |
 Morning and evening | 92 (23.8%) |
 Multiples times per day (> 2) | 46 (11.9%) |
 When needed | 78 (20.2%) |
 Other | 2 (0.5%) |
Routes of administration (n = 387) | |
 Sublingual | 281 (72.6%) |
 Capsules/pills | 68 (17.6%) |
 Topical (on skin) | 54 (14%) |
 Vaping | 36 (9.3%) |
 Edibles | 33 (8.5%) |
 Drinking | 26 (6.7%) |
 Spray (via mouth) | 20 (5.2%) |
 Smoking | 18 (4.7%) |
 Suppository (vaginal/rectal) | 3 (0.8%) |
 Other | 13 (3.4%) |
Dose of CBD per day in mg (n = 373) | |
 0–24 | 110 (29.5%) |
 25–49 | 93 (24.9%) |
 50–99 | 69 (18.5%) |
 100–149 | 25 (6.7%) |
 150–199 | 11 (2.9%) |
 ≥ 200 | 27 (7.24%) |
 I do not know | 38 (10.2%) |